Priming adult stem cells by hypoxic pretreatments for applications in regenerative medicine

Journal of Biomedical Science

Volumn 20, Issue 1, 2013, Pages

  Muscari, Claudio ^a,b,d   Giordano, Emanuele ^b,c,d   Bonafè, Francesca ^a,b   Govoni, Marco ^d   Pasini, Alice ^c   Guarnieri, Carlo ^a,b,d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b National Institute for Cardiovascular Research   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Apoptosis; Cell differentiation; Hypoxia; Preconditioning; Reoxygenation; Stem cell

Indexed keywords

DIAZOXIDE; HYPOXIA INDUCIBLE FACTOR; MICRORNA;

ADULT STEM CELL; APOPTOSIS; CELL DIFFERENTIATION; CELL PROTECTION; CHEMICAL MODIFICATION; CHONDROGENESIS; EPIGENETICS; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HYPOXIA; ISCHEMIC PRECONDITIONING; MICROENVIRONMENT; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; REGENERATIVE MEDICINE; REVIEW; SIGNAL TRANSDUCTION; STEM CELL NICHE; ADULT; CELL HYPOXIA; CELL SURVIVAL; CYTOLOGY; HEART INFARCTION PREVENTION; METABOLISM; METHODOLOGY;

ADULT; ADULT STEM CELLS; CELL DIFFERENTIATION; CELL HYPOXIA; CELL SURVIVAL; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; REGENERATIVE MEDICINE;

EID: 84883109616     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-20-63     Document Type: Review

References (139)

1. Differentiation and proliferation of hematopoietic stem cells. Ogawa M, Blood 1993 81 11 2844 2853 (Pubitemid 23162099)
2. Divisional history and pluripotency of human hematopoietic stem cells. Punzel M, Ho AD, Ann N Y Acad Sci 2001 938 72 81
3. Stem cells. Behr B, Ko SH, Wong VW, Gurtner GC, Longaker MT, Plast Reconstr Surg 2010 126 4 1163 1171
4. Introduction to stem cells and regenerative medicine. Kolios G, Moodley Y, Respiration 2013 85 1 3 10
5. Generation of induced pluripotent stem cells from somatic cells. Sohn YD, Han JW, Yoon YS, Prog Mol Biol Transl Sci 2012 111 1 26
6. Evidence for bone marrow adult stem cell plasticity: properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation. Catacchio I, Berardi S, Reale A, De Luisi A, Racanelli V, Vacca A, Ria R, Stem Cells Int 2013 2013 589139
7. Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury. Kucia M, Ratajczak J, Reca R, Janowska-Wieczorek A, Ratajczak MZ, Blood Cells Mol Dis 2004 32 1 52 57 (Pubitemid 38147696)
8. Enhanced cell transplantation: preventing apoptosis increases cell survival and ventricular function. Nakamura Y, Yasuda T, Weisel RD, Li RK, Am J Physiol Heart Circ Physiol 2006 291 2 939 H947
9. Interventional strategies to prevent beta-cell apoptosis in islet transplantation. Emamaullee JA, Shapiro AM, Diabetes 2006 55 7 1907 1914 (Pubitemid 44509961)
10. Anoikis, extracellular matrix, and apoptosis factors in isolated cell transplantation. Thomas FT, Contreras JL, Bilbao G, Ricordi C, Curiel D, Thomas JM, Surgery 1999 126 2 299 304 (Pubitemid 29382795)
11. Restored perfusion and reduced inflammation in the infarcted heart after grafting stem cells with a hyaluronan-based scaffold. Muscari C, Bonafè F, Martin-Suarez S, Valgimigli S, Valente S, Fiumana E, Fiorelli F, Rubini G, Guarnieri C, Caldarera CM, Capitani O, Arpesella G, Pasquinelli G, J Cell Mol Med 2013 17 4 518 530
12. Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure. Bonaros N, Rauf R, Werner E, Schlechta B, Rohde E, Kocher A, Bonatti J, Laufer G, Interact Cardiovasc Thorac Surg 2008 7 2 249 255 (Pubitemid 351497555)
13. Localization of mesenchymal stem cells grafted with a hyaluronan-based scaffold in the infarcted heart. Fiumana E, Pasquinelli G, Foroni L, Carboni M, Bonafé F, Orrico C, Nardo B, Tsivian M, Neri F, Arpesella G, Guarnieri C, Caldarera CM, Muscari C, J Surg Res 2013 179 1 21 e29
14. Cardiac cell therapy: pre-conditioning effects in cell-delivery strategies. Wu KH, Mo XM, Han ZC, Zhou B, Cytotherapy 2012 14 3 260 266
15. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats. Najafi R, Sharifi AM, Expert Opin Biol Ther 2013 13 7 959 972
16. Molecular mechanisms of liver preconditioning. Alchera E, Dal Ponte C, Imarisio C, Albano E, Carini R, World J Gastroenterol 2010 16 48 6058 6067
17. Ischemic preconditioning reduces endoplasmic reticulum stress and upregulates hypoxia inducible factor-1 in ischemic kidney: the role of nitric oxide. Mahfoudh-Boussaid A, Zaouali MA, Hadj-Ayed K, Miled AH, Saidane-Mosbahi D, Rosello-Catafau J, Ben Abdennebi H, J Biomed Sci 2012 7 2 32296
18. Ischemic preconditioning and clinical scenarios. Narayanan SV, Dave KR, Perez-Pinzon M, Curr Opin Neurol 2013 26 1 1 7
19. Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection. Babu GG, Walker JM, Yellon DM, Hausenloy DJ, Eur Heart J 2011 32 1 23 31
20. Myocardial protection in adult cardiac surgery: current options and future challenges. Nicolini F, Beghi C, Muscari C, Agostinelli A, Maria Budillon A, Spaggiari I, Gherli T, Eur J Cardiothorac Surg 2003 24 6 986 993 (Pubitemid 37476376)
21. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Schofield R, Blood Cells 1978 4 1-2 7 25 (Pubitemid 8376317)
22. A stem cell molecular signature. Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, Lemischka IR, Science 2002 298 5593 601 604
23. Hyaluronan regulates cell behavior: a potential niche matrix for stem cells. Solis MA, Chen YH, Wong TY, Bittencourt VZ, Lin YC, Huang LL, Biochem Res Int 2012 2012 346972
24. Stem cell niche in tissue homeostasis, aging and cancer. Singh SR, Curr Med Chem 2012 19 35 5965 5974
25. Oxygen in stem cell biology: a critical component of the stem cell niche. Mohyeldin A, Garzón-Muvdi T, Quiñones-Hinojosa A, Cell Stem Cell 2010 7 2 150 161
26. The stem cell niche in health and malignancy. Burness ML, Sipkins DA, Semin Cancer Biol 2010 20 2 107 115
27. Low O2 tensions and the prevention of differentiation of hES cells. Ezashi T, Das P, Roberts RM, Proc Natl Acad Sci U S A 2005 102 13 4783 4788 (Pubitemid 40471531)
28. The cancer stem cell niche-there goes the neighborhood? Cabarcas SM, Mathews LA, Farrar WL, Int J Cancer 2011 129 10 2315 2327
29. Hypoxia-induced oxidative stress in health disorders. Pialoux V, Mounier R, Oxid Med Cell Longev 2012 2012 940121
30. HIF hits Wnt in the stem cell niche. Kaufman DS, Nat Cell Biol 2010 12 10 926 927
31. Hypoxia signalling in cancer and approaches to enforce tumour regression. Pouysségur J, Dayan F, Mazure NM, Nature 2006 441 7092 437 443 (Pubitemid 44050138)
32. HIF-1: the knowns and unknowns of hypoxia sensing. Zagorska A, Dulak J, Acta Biochim 2004 51 3 563 585 (Pubitemid 39296914)
33. Prolyl hydroxylases as regulators of cell metabolism. Boulahbel H, Durán RV, Gottlieb E, Biochem Soc Trans 2009 37 Pt 1 291 294
34. Hypoxia-inducible factors and the response to hypoxic stress. Majmundar AJ, Wong WJ, Simon MC, Mol Cell 2010 40 2 294 309
35. Integration of oxygen signaling at the consensus HRE. Wenger RH, Stiehl DP, Camenisch G, Sci STKE 2005 2005 306 e12
36. Hypoxia-regulated target genes implicated in tumor metastasis. Tsai YP, Wu KJ, J Biomed Sci 2012 19 102
37. Hypoxia-inducible factor as a therapeutic target for cardioprotection. Ong SG, Hausenloy DJ, Pharmacol Ther 2012 136 1 69 81
38. Hypoxia-induced and stress-specific changes in chromatin structure and function. Johnson AB, Barton MC, Mutat Res 2007 618 1-2 149 162 (Pubitemid 46574738)
39. Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene. Wang F, Zhang R, Beischlag TV, Muchardt C, Yaniv M, Hankinson O, J Biol Chem 2004 279 45 46733 46741 (Pubitemid 39518321)
40. SWI/SNF regulates the cellular response to hypoxia. Kenneth NS, Mudie S, van Uden P, Rocha S, J Biol Chem 2009 284 7 4123 4131
41. Drosophila genome-wide RNAi screen identifies multiple regulators of HIF-dependent transcription in hypoxia. Dekanty A, Romero NM, Bertolin AP, Thomas MG, Leishman CC, Perez-Perri JI, Boccaccio GL, Wappner P, PLoS Genet 2010 6 6 1000994
42. Hypoxia induces a novel signature of chromatin modifications and global repression of transcription. Johnson AB, Denko N, Barton MC, Mutat Res 2008 640 1-2 174 179
43. Dynamic regulation of histone lysine methylation by demethylases. Shi Y, Whetstine JR, Mol Cell 2007 25 1 1 14 (Pubitemid 46049067)
44. Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha. Pollard PJ, Loenarz C, Mole DR, McDonough MA, Gleadle JM, Schofield CJ, Ratcliffe PJ, Biochem J 2008 416 3 387 394
45. Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Loh YH, Zhang W, Chen X, George J, Ng HH, Genes Dev 2007 21 20 2545 57 (Pubitemid 47607666)
46. Hypoxia induces re-entry of committed cells into pluripotency. Mathieu J, Zhang Z, Nelson A, Lamba DA, Reh TA, Ware C, Ruohola-Baker H, Stem Cells 2013 in press 10.1002/stem.1446
47. Accelerated generation of human induced pluripotent stem cells with retroviral transduction and chemical inhibitors under physiological hypoxia. Shimada H, Hashimoto Y, Nakada A, Shigeno K, Nakamura T, Biochem Biophys Res Commun 2012 417 2 659 664
48. Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier. Watanabe A, Yamada Y, Yamanaka S, Philos Trans R Soc Lond B Biol Sci 2013 368 1609 20120292
49. Navigating the epigenetic landscape of pluripotent stem cells. Li M, Liu GH, Izpisua Belmonte JC, Nat Rev Mol Cell Biol 2012 13 8 524 535
50. Epigenetic signature of early cardiac regulatory genes in native human adipose-derived stem cells. Pasini A, Bonafè F, Govoni M, Guarnieri C, Morselli PG, Sharma HS, Caldarera CM, Muscari C, Giordano E, Cell Biochem Biophys 2013 in press 10.1007/s12013-013-9610-z
51. Suffocating cancer: hypoxia-associated epimutations as targets for cancer therapy. Thirlwell C, Schulz L, Dibra H, Beck S, Clin Epigenetics 2011 3 9
52. Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Chen H, Yan Y, Davidson TL, Shinkai Y, Costa M, Cancer Res 2006 66 18 9009 9016 (Pubitemid 44521119)
53. Micro-RNA mediated regulation of proliferation, self-renewal and differentiation of mammalian stem cells. Hime GR, Somers WG, Cell Adh Migr 2009 3 4 425 432
54. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. Hua Z, Lv Q, Ye W, Wong CK, Cai G, Gu D, Ji Y, Zhao C, Wang J, Yang BB, Zhang Y, PLoS One 2006 1 116
55. Roles of the hypoxia response system in hematopoietic and leukemic stem cells. Takubo K, Suda T, Int J Hematol 2012 95 5 478 483
56. Complexity of cancer stem cells. Sugihara E, Saya H, Int J Cancer 2013 132 6 1249 1259
57. Hypoxia inducible factors in cancer stem cells. Heddleston JM, Li Z, Lathia JD, Bao S, Hjelmeland AB, Rich JN, Br J Cancer 2010 102 5 789 795
58. Interventions that induce modifications in the tumor microenvironment. Bernhard EJ, Cancer Radiother 2011 15 5 376 382
59. Time course of apoptotic cell death within mesencephalic cell suspension grafts: implications for improving grafted dopamine neuron survival. Sortwell CE, Pitzer MR, Collier TJ, Exp Neurol 2000 165 2 268 277
60. Intramitochondrial signaling: interactions among mitoK§ssub§ ATP§esub§, PKC§ssub§ε§esub§, ROS, and MPT. Costa AD, Garlid KD, Am J Physiol Heart Circ Physiol 2008 295 2 874 H882
61. Ischemic preconditioning preserves proton leakage from mitochondrial membranes but not oxidative phosphorylation during heart reperfusion. Muscari C, Bonafè F, Gamberini C, Giordano E, Lenaz G, Caldarera CM, Cell Biochem Funct 2006 24 6 511 518
62. Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells. Wang JA, Chen TL, Jiang J, Shi H, Gui C, Luo RH, Xie XJ, Xiang MX, Zhang X, Acta Pharmacol Sin 2008 29 1 74 82
63. Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. Chacko SM, Ahmed S, Selvendiran K, Kuppusamy ML, Khan M, Kuppusamy P, Am J Physiol Cell Physiol 2010 299 6 1562 C1570
64. Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. Haider HK, Ashraf M, J Mol Cell Cardiol 2008 45 4 554 566
65. Hypoxic preconditioning increases survival and angiogenic potency of peripheral blood mononuclear cells via oxidative stress resistance. Kubo M, Li TS, Suzuki R, Shirasawa B, Morikage N, Ohshima M, Qin SL, Hamano K, Am J Physiol Heart Circ Physiol 2008 294 2 590 H595
66. Improved survival of mesenchymal stromal cell after hypoxia preconditioning: role of oxidative stress. Peterson KM, Aly A, Lerman A, Lerman LO, Rodriguez-Porcel M, Life Sci 2011 88 1-2 65 73
67. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Rosová I, Dao M, Capoccia B, Link D, Nolta JA, Stem Cells 2008 26 8 2173 2182
68. Preconditioning and stem cell survival. Haider HK, Ashraf M, J Cardiovasc Transl Res 2010 3 2 89 102
69. Hypoxia-preconditioned mesenchymal stromal cells improve cardiac function in a swine model of chronic myocardial ischaemia. Jaussaud J, Biais M, Calderon J, Chevaleyre J, Duchez P, Ivanovic Z, Couffinhal T, Barandon L, Eur J Cardiothorac Surg 2013 43 5 1050 1057
70. Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy. Li JH, Zhang N, Wang JA, J Endocrinol Invest 2008 31 2 103 110 (Pubitemid 351596969)
71. Hypoxia preconditioned mesenchymal stem cells improve vascular and skeletal muscle fiber regeneration after ischemia through a Wnt4-dependent pathway. Leroux L, Descamps B, Tojais NF, Séguy B, Oses P, Moreau C, Daret D, Ivanovic Z, Boiron JM, Lamazière JM, Dufourcq P, Couffinhal T, Duplàa C, Mol Ther 2010 18 8 1545 1552
72. The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury. Liu H, Liu S, Li Y, Wang X, Xue W, Ge G, Luo X, PLoS One 2012 7 4 34608
73. Hypoxic preconditioning with cobalt of bone marrow mesenchymal stem cells improves cell migration and enhances therapy for treatment of ischemic acute kidney injury. Yu X, Lu C, Liu H, Rao S, Cai J, Liu S, Kriegel AJ, Greene AS, Liang M, Ding X, PLoS One 2013 8 5 62703
74. Identification of cyclooxygenase-2 as a major actor of the transcriptomic adaptation of endothelial and tumor cells to cyclic hypoxia: effect on angiogenesis and metastases. Daneau G, Boidot R, Martinive P, Feron O, Clin Cancer Res 2010 16 2 410 419
75. Hypoxia response and microRNAs: no longer two separate worlds. Ivan M, Harris AL, Martelli F, Kulshreshtha R, J Cell Mol Med 2008 12 5A 1426 1431
76. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. Kim HW, Haider HK, Jiang S, Ashraf M, J Biol Chem 2009 284 48 33161 33168
77. Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function. Kim HW, Jiang S, Ashraf M, Haider KH, J Mol Med (Berl) 2012 90 9 997 1010
78. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, Capogrossi MC, Martelli F, J Biol Chem 2008 283 23 15878 15883
79. A microRNA component of the hypoxic response. Kulshreshtha R, Davuluri RV, Calin GA, Ivan M, Cell Death Differ 2008 15 4 667 671 (Pubitemid 351405070)
80. Concomitant activation of miR-107/PDCD10 and Hypoxamir-210/Casp8ap2 and their role in cytoprotection during ischemic preconditioning of stem cells. Kim HW, Mallick F, Durrani S, Ashraf M, Jiang S, Haider KH, Antioxid Redox Signal 2012 17 8 1053 1065
81. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Tang YL, Zhu W, Cheng M, Chen L, Zhang J, Sun T, Kishore R, Phillips MI, Losordo DW, Qin G, Circ Res 2009 104 10 1209 1216
82. Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1 in MSCs. Liu H, Xue W, Ge G, Luo X, Li Y, Xiang H, Ding X, Tian P, Tian X, Biochem Biophys Res Commun 2010 401 4 509 515
83. HIF-1 is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway. Qiang L, Wu T, Zhang HW, Lu N, Hu R, Wang YJ, Zhao L, Chen FH, Wang XT, You QD, Guo QL, Cell Death Differ 2012 19 2 284 294
84. Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells. Xing F, Okuda H, Watabe M, Kobayashi A, Pai SK, Liu W, Pandey PR, Fukuda K, Hirota S, Sugai T, Wakabayshi G, Koeda K, Kashiwaba M, Suzuki K, Chiba T, Endo M, Mo YY, Watabe K, Oncogene 2011 30 39 4075 4086
85. Multiplicity of effectors of the cardioprotective agent, diazoxide. Coetzee WA, Pharmacol Ther 2013 in press 10.1016/j.pharmthera.2013.06.007
86. Myocardial ischaemic and diazoxide preconditioning both increase PGC-1alpha and reduce mitochondrial damage. Han JS, Wang HS, Yan DM, Wang ZW, Han HG, Zhu HY, Li XM, Acta Cardiol 2010 65 6 639 644
87. The direct physiological effects of mitoK(ATP) opening on heart mitochondria. Costa AD, Quinlan CL, Andrukhiv A, West IC, Jabůrek M, Garlid KD, Am J Physiol Heart Circ Physiol 2006 290 1 406 H415
88. Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappaB signaling. Afzal MR, Haider HK, Idris NM, Jiang S, Ahmed RP, Ashraf M, Antioxid Redox Signal 2010 12 6 693 702
89. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Niagara MI, Haider HK, Jiang S, Ashraf M, Circ Res 2007 100 4 545 555 (Pubitemid 46673264)
90. A review of the current research on the role of bFGF and VEGF in angiogenesis. Przybylski M, J Wound Care 2009 18 12 516 619
91. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). Byrne AM, Bouchier-Hayes DJ, Harmey JH, J Cell Mol Med 2005 9 4 777 794 (Pubitemid 43116546)
92. VEGF in biological control. Breen EC, J Cell Biochem 2007 102 6 1358 1367 (Pubitemid 350223939)
93. Pharmacologically active microcarriers for endothelial progenitor cell support and survival. Musilli C, Karam JP, Paccosi S, Muscari C, Mugelli A, Montero-Menei CN, Parenti A, Eur J Pharm Biopharm 2012 81 3 609 616
94. Pharmacologically active microcarriers influence VEGF-A effects on mesenchymal stem cell survival. Penna C, Perrelli MG, Karam JP, Angotti C, Muscari C, Montero-Menei CN, Pagliaro P, J Cell Mol Med 2013 17 1 192 204
95. Different expression of NOS isoforms in early endothelial progenitor cells derived from peripheral and cord blood. Muscari C, Gamberini C, Carboni M, Basile I, Farruggia G, Bonafè F, Giordano E, Caldarera CM, Guarnieri C, J Cell Biochem 2007 102 4 992 1001 (Pubitemid 350036938)
96. Comparison between culture conditions improving growth and differentiation of blood and bone marrow cells committed to the endothelial cell lineage. Muscari C, Gamberini C, Basile I, Bonafé F, Valgimigli S, Capitani O, Guarnieri C, Caldarera CM, Biol Proced Online 2010 12 1 9023
97. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Tepper OM, Capla JM, Galiano RD, Ceradini DJ, Callaghan MJ, Kleinman ME, Gurtner GC, Blood 2005 105 3 1068 1077 (Pubitemid 40170877)
98. Effective cardiac myocy te differentiation of human induced pluripotent stem cells requires VEGF. Ye L, Zhang S, Greder L, Dutton J, Keirstead SA, Lepley M, Zhang L, Kaufman D, Zhang J, PLoS One 2013 8 1 53764
99. Dual effects of isoflurane on proliferation, differentiation, and survival in human neuroprogenitor cells. Zhao X, Yang Z, Liang G, Wu Z, Peng Y, Joseph DJ, Inan S, Wei H, Anesthesiology 2013 118 3 537 549
100. Interleukin 6-preconditioned neural stem cells reduce ischaemic injury in stroke mice. Sakata H, Narasimhan P, Niizuma K, Maier CM, Wakai T, Chan PH, Brain 2012 135 Pt 11 3298 3310
101. Stem cell-like human endothelial progenitors show enhanced colony-forming capacity after brief sevoflurane exposure: preconditioning of angiogenic cells by volatile anesthetics. Lucchinetti E, Zeisberger SM, Baruscotti I, Wacker J, Feng J, Zaugg K, Dubey R, Zisch AH, Zaugg M, Anesth Analg 2009 109 4 1117 1126
102. Preconditioning of stem cells by oxytocin to improve their therapeutic potential. Noiseux N, Borie M, Desnoyers A, Menaouar A, Stevens LM, Mansour S, Danalache BA, Roy DC, Jankowski M, Gutkowska J, Endocrinology 2012 153 11 5361 5372
103. Angiopoietin-1 preconditioning enhances survival and functional recovery of mesenchymal stem cell transplantation. Liu XB, Chen H, Chen HQ, Zhu MF, Hu XY, Wang YP, Jiang Z, Xu YC, Xiang MX, Wang JA, J Zhejiang Univ Sci B 2012 13 8 616 623
104. Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction. Zhang J, Chen GH, Wang YW, Zhao J, Duan HF, Liao LM, Zhang XZ, Chen YD, Chen H, Chin Med J (Engl) 2012 125 19 3472 3478
105. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. Herrmann JL, Wang Y, Abarbanell AM, Weil BR, Tan J, Meldrum DR, Shock 2010 33 1 24 30
106. Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression. Wisel S, Khan M, Kuppusamy ML, Mohan IK, Chacko SM, Rivera BK, Sun BC, Hideg K, Kuppusamy P, J Pharmacol Exp Ther 2009 329 2 543 550
107. Preconditioning by phosphodiesterase-5 inhibition improves therapeutic efficacy of adipose-derived stem cells following myocardial infarction in mice. Hoke NN, Salloum FN, Kass DA, Das A, Kukreja RC, Stem Cells 2012 30 2 326 335
108. The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release. Cai C, Teng L, Vu D, He JQ, Guo Y, Li Q, Tang XL, Rokosh G, Bhatnagar A, Bolli R, J Biol Chem 2012 287 40 33720 33732
109. Adult neural stem cells bridge their niche. Fuentealba LC, Obernier K, Alvarez-Buylla A, Cell Stem Cell 2012 10 6 698 708
110. Concise review: quiescent and active states of endogenous adult neural stem cells: identification and characterization. Wang YZ, Plane JM, Jiang P, Zhou CJ, Deng W, Stem Cells 2011 29 6 907 912
111. Stem cells for ischemic brain injury: a critical review. Burns TC, Verfaillie CM, Low WC, J Comp Neurol 2009 515 1 125 144
112. Stem cell maintenance in the adult mammalian hippocampus: a matter of signal integration? Schwarz TJ, Ebert B, Lie DC, Dev Neurobiol 2012 72 7 1006 1015
113. Tissue oxygen tension and brain sensitivity to hypoxia. Erecińska M, Silver IA, Respir Physiol 2001 128 3 263 276 (Pubitemid 33051004)
114. Modulation of neuronal stem cell differentiation by hypoxia and reactive oxygen species. Vieira HL, Alves PM, Vercelli A, Prog Neurobiol 2011 93 3 444 455
115. Synergistic effects of CoCl(2) and ROCK inhibition on mesenchymal stem cell differentiation into neuron-like cells. Pacary E, Legros H, Valable S, Duchatelle P, Lecocq M, Petit E, Nicole O, Bernaudin M, J Cell Sci 2006 119 Pt13 2667 2678 (Pubitemid 44184003)
116. Redox regulation of stem/progenitor cells and bone marrow niche. Urao N, Ushio-Fukai M, Free Radic Biol Med 2013 54 26 39
117. Hyperoxia induces the differentiated neuronal phenotype of PC12 cells by producing reactive oxygen species. Katoh S, Mitsui Y, Kitani K, Suzuki T, Biochem Biophys Res Commun 1997 241 2 347 351 (Pubitemid 28020104)
118. Regulation of life span by mitochondrial respiration: the HIF-1 and ROS connection. Hwang AB, Lee SJ, Aging (Albany NY) 2011 3 3 304 310
119. Hypoxia promotes chondrogenesis in rat mesenchymal stem cells: a role for AKT and hypoxia-inducible factor (HIF)-1alpha. Kanichai M, Ferguson D, Prendergast PJ, Campbell VA, J Cell Physiol 2008 216 3 708 715
120. Hypoxia-inducible factor 2 alpha is essential for hypoxic induction of the human chondrocyte phenotype. Murphy CL, Lafont JE, Talma S, Arthitis Rheum 2007 56 10 3297 3306 (Pubitemid 47585424)
121. Hypoxia inhibits osteogenesis in human mesenchymal stem cells through direct regulation of RUNX2 by TWIST. Yang DC, Yang MH, Tsai CC, Huang TF, Chen YH, Hung SC, PLoS One 2011 6 9 23965
122. Molecular and biophysical mechanisms regulating hypertrophic differentiation in chondrocytes and mesenchymal stem cells. Studer D, Millan C, Öztürk E, Maniura-Weber K, Zenobi-Wong M, Eur Cell Mater 2012 24 118 135
123. Molecular mechanism of hypoxia-induced chondrogenesis and its application in in vivo cartilage tissue engineering. Duval E, Baugé C, Andriamanalijaona R, Bénateau H, Leclercq S, Dutoit S, Poulain L, Galéra P, Boumédiene K, Biomaterials 2012 33 26 6042 6051
124. Hypoxic conditions during expansion culture prime human mesenchymal stromal precursor cells for chondrogenic differentiation in three-dimensional cultures. Müller J, Benz K, Ahlers M, Gaissmaier C, Mollenhauer J, Cell Transplant 2011 20 10 1589 1602
125. Comparison between stem cells harvested from wet and dry lipoaspirates. Muscari C, Bonafè F, Fiumana E, Oranges CM, Pinto V, Caldarera CM, Guarnieri C, Morselli PG, Connect Tissue Res 2013 54 1 34 40
126. Differential effects of hypoxia on osteochondrogenic potential of human adipose-derived stem cells. Merceron C, Vinatier C, Portron S, Masson M, Amiaud J, Guigand L, Chérel Y, Weiss P, Guicheux J, Am J Physiol Cell Physiol 2010 298 2 355 C364
127. Effect of reduced oxygen tension on chondrogenesis and osteogenesis in adipose-derived mesenchymal cells. Malladi P, Xu Y, Chiou M, Giaccia AJ, Longaker MT, Am J Physiol Cell Physiol 2006 290 4 1139 C1146
128. Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. Wen Z, Zheng S, Zhou C, Wang J, Wang T, J Cell Mol Med 2011 15 5 1032 1043
129. Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury. Chang CP, Chio CC, Cheong CU, Chao CM, Cheng BC, Lin MT, Clin Sci (Lond) 2013 124 3 165 176
130. Switching off angiogenic signalling: creating channelled constructs for adequate oxygen delivery in tissue engineered constructs. Cheema U, Alekseeva T, Abou-Neel EA, Brown RA, Eur J Mater 2010 20 274 280
131. Cardioprotection from ischemia/reperfusion injury: basic and translational research. Minamino T, Circ J 2012 76 5 1074 1082
132. Mitochondrial pathways, permeability transition pore, and redox signaling in cardioprotection: therapeutic implications. Penna C, Perrelli MG, Pagliaro P, Antioxid Redox Signal 2013 18 5 556 599
133. Mitochondrial reactive oxygen species-Which ROS signals cardioprotection? Garlid AO, Jaburek M, Jacobs JP, Garlid KD, Am J Physiol Heart Circ Physiol 2013 in press 10.1152/ajpheart.00858.2012
134. The late phase of preconditioning. Bolli R, Circ Res 2000 87 11 972 983
135. Adenosine as an adjunct to reperfusion in myocardial infarction. Maurer G, Eur Heart J 2006 27 20 2376 2377 (Pubitemid 44522136)
136. EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVAL EPC substudy. Povsic TJ, Najiar SS, Prather K, Zhou J, Adams SD, Zavodni KL, Kelly F, Melton LG, Hasselblad V, Heitner JF, Raman SV, Barsness GW, Patel MR, Kim RJ, Lakatta EG, Harrington RA, Rao SV, J Thromb Thombolysis 2013 in press 10.1007/s11239-013-0944-6
137. Combining adult stem cells and polymeric devices for tissue engineering in infarcted myocardium. Karam JP, Muscari C, Montero-Menei CN, Biomaterials 2012 33 23 5683 5695
138. An innovative stand-alone bioreactor for the highly reproducible transfer of cyclic mechanical stretch to stem cells cultured in a 3D scaffold. Govoni M, Lotti F, Biagiotti L, Lannocca M, Pasquinelli G, Valente S, Muscari C, Bonafè F, Caldarera CM, Guarnieri C, Cavalcanti S, Giordano E, J Tissue Eng Regen Med 2012 in press 10.1002/term.1578
139. The roles of hypoxia in the in vitro engineering of tissues. Malda J, Klein TJ, Upton Z, Tissue Eng 2007 13 9 2153 2162 (Pubitemid 47404431)